<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="62143">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01993836</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00045180</org_study_id>
    <nct_id>NCT01993836</nct_id>
  </id_info>
  <brief_title>Markers of Alzheimers Disease and Cognitive Outcomes After Propofol or Isoflurane Anesthesia</brief_title>
  <acronym>MADCO-PIA</acronym>
  <official_title>Markers of Alzheimers Disease and Cognitive Outcomes After Propofol or Isoflurane Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will examine the hypothesis that changes in the cognition (i.e. thinking and
      memory) after anesthesia and surgery are correlated with changes in markers of Alzheimers
      Disease in the fluid around the brain and spinal cord (i.e. cerebrospinal fluid, or CSF).
      The investigators will also examine whether different types of anesthesia have different
      effects on these CSF markers of Alzheimers disease, or different effects on thinking and
      memory after anesthesia and surgery, or differential effects on the correlation between
      cognitive changes and CSF marker changes.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">November 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Perioperative CSF Tau/Abeta ratio change</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will measure the perioperative change in the CSF tau/Abeta ratio from the start of anesthesia/surgery to 24 hours later.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Continuous cognitive index score change</measure>
    <time_frame>6 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will examine the difference in the continuous cognitive index score over time in the subjects treated with propofol versus those treated with isoflurane.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assess the correlation between perioperative change in CSF Markers of Alzheimers Disease and perioperative cognitive change.</measure>
    <time_frame>6 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will assess the magnitude of the pearson correlation coefficient for the relationship between perioperative change in CSF Markers of Alzheimers Disease and the perioperative change in the continuous cognitive index score.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Alzheimers Disease</condition>
  <condition>Postoperative Delirium</condition>
  <condition>Post Operative Cognitive Dysfunction</condition>
  <arm_group>
    <arm_group_label>Total Intravenous Anesthesia with Propofol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this arm will receive general anesthesia with propofol as the primary amnestic agent.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>General anesthesia with Isoflurane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this arm will undergo general anesthesia with isoflurane as the primary amnestic agent.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Total intravenous anesthesia with propofol</intervention_name>
    <arm_group_label>Total Intravenous Anesthesia with Propofol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>General anesthesia with isoflurane</intervention_name>
    <arm_group_label>General anesthesia with Isoflurane</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Surgical patients 60 years of age or older

          -  Surgery scheduled to last at least 2 hours (including time for anesthesia induction,
             etc)

          -  English speaking ability.

          -  Ability to give informed consent

        Exclusion Criteria:

          -  Inmate of a correctional facility (i.e. prisoners).

          -  Pregnancy

          -  Documented or suspected family or personal history of malignant     hyperthermia.

          -  Patient unable to receive either propofol or isoflurane due to allergy or other
             specific contraindication.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Miles Berger, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University Medical Center, Anesthesiology Department, Neuroanesthesia Division</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Miles Berger, MD, PhD</last_name>
    <email>miles.berger@duke.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miles Berger, MD, PhD</last_name>
      <email>miles.berger@duke.edu</email>
    </contact>
    <contact_backup>
      <last_name>Carlos Conde</last_name>
      <email>carlos.conde@duke.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Miles Berger, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 21, 2013</lastchanged_date>
  <firstreceived_date>November 15, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>isoflurane</keyword>
  <keyword>propofol</keyword>
  <keyword>total intravenous anesthesia</keyword>
  <keyword>inhaled anesthetic</keyword>
  <keyword>volatile anesthetic</keyword>
  <keyword>anesthesia</keyword>
  <keyword>delirium</keyword>
  <keyword>Post Operative Cognitive Dysfunction</keyword>
  <keyword>Alzheimer's Disease</keyword>
  <keyword>Mild Cognitive Impairment</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Delirium</mesh_term>
    <mesh_term>Cognition Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Isoflurane</mesh_term>
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
